NCT03414437View on ClinicalTrials.gov

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

UnknownOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Prostate Cancer Metastatic
Trial Locations (5)

13210

Associated Medical Professionals, Syracuse

21204

Chesapeake urology Research Associates, Towson

29572

Carolina Urologic Research Center, Myrtle Beach

68130

Urology Cancer Center and GU Research Network, Omaha

97477

Oregon Urology Institute, Springfield

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Carolina Research Professionals, LLC

OTHER

NCT03414437 - Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303) | Biotech Hunter | Biotech Hunter